These topics include the impact of obesity on KRAS activity, the role of visceral adipose tissue, intrapancreatic fat, adipose tissue inflammation, and adipokines on pancreatic cancer development. Here, KRAS is linked to obesity due to melanocortin 4 receptor deficiency.